GlassScriptPhysician profile
Steven D Enrich
NPI 1689858201
$11,324.14
in general payments reported to CMS, 2019-2025
19 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,158 · 2020: $1,102 · 2021: $2,324 · 2022: $2,652 · 2023: $366 · 2024: $236 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,088.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,660.54 | 2019-2025 | Xpress Ent Dilation System, Clarifix Cryotherapy Device, Scopis Ent |
| Intersect Ent, INC. | $3,087.40 | 2019-2021 | |
| Acclarent, INC | $412.43 | 2019-2022 | |
| Aerin Medical INC. | $398.15 | 2019-2025 | |
| Olympus America INC. | $197.49 | 2019-2025 | Rhino-Laryngo Videoscope |
| Alk-Abello, INC | $90.49 | 2021-2022 | |
| Glaxosmithkline, LLC. | $79.77 | 2022-2023 | Nucala |
| Novartis Pharmaceuticals Corporation | $58.39 | 2019 | |
| Genzyme Corporation | $58.18 | 2021-2022 | |
| Optinose US, INC. | $48.19 | 2020 | |
| Kaleo, INC. | $43.17 | 2021 | |
| Integra Lifesciences Corporation | $36.75 | 2019 | |
| Neurent Medical Limited | $35.84 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Inspire Medical Systems, INC. | $32.40 | 2024 | Inspire |
| Amgen INC. | $20.54 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.30 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $15.94 | 2023 | Dupixent |
| Clarus Therapeutics INC. | $15.35 | 2021 | |
| Medtronic, INC. | $13.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Enrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.